In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci.
Roveta
S
S
Marchese
A
A
Debbia
E A
EA
Bandettini
R
R
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004338:Drug Combinations; D024881:Drug Resistance, Bacterial; D004357:Drug Synergism; D008826:Microbial Sensitivity Tests; D015644:Miocamycin / Q000031:analogs & derivatives / Q000494:pharmacology; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000254:growth & development; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000254:growth & development; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015644:Miocamycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; C033383:rokitamycin